摘要
腹水是肝硬化晚期最常见的并发症之一,大约有10%的患者最终发展为难治性腹水。难治性腹水并发症多,临床疗效差,不仅影响患者的生活质量,而且对远期的存活时间有很大影响。本文就国内外关于肝硬化腹水的治疗现状与进展作一综述。
Ascites is one of the most common complications of advanced liver cirrhosis, and about 10% of the patients eventually develop into refractory ascites. Refractory ascites will bring about complications and poor clinical efficacy; it not only affects the patients＇ quality of life, and has a great impact on their survival. The treatment and progress of liver cirrhosis with ascites at home and abroad are reviewed in this article.
出处
《辽宁医学院学报》
CAS
2012年第4期373-375,共3页
Journal of Liaoning Medical University (LNMU) Bimonthly
关键词
肝硬化
腹水
治疗
cirrhosis
ascites
treatment
